Gayoso, Adam http://orcid.org/0000-0001-9537-0845
Lopez, Romain http://orcid.org/0000-0003-0495-738X
Xing, Galen
Boyeau, Pierre
Valiollah Pour Amiri, Valeh http://orcid.org/0000-0002-2008-5297
Hong, Justin http://orcid.org/0000-0003-2115-9101
Wu, Katherine
Jayasuriya, Michael
Mehlman, Edouard
Langevin, Maxime
Liu, Yining
Samaran, Jules
Misrachi, Gabriel
Nazaret, Achille
Clivio, Oscar
Xu, Chenling http://orcid.org/0000-0001-9610-7627
Ashuach, Tal
Gabitto, Mariano
Lotfollahi, Mohammad http://orcid.org/0000-0001-6858-7985
Svensson, Valentine
da Veiga Beltrame, Eduardo
Kleshchevnikov, Vitalii
Talavera-López, Carlos
Pachter, Lior http://orcid.org/0000-0002-9164-6231
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
Streets, Aaron http://orcid.org/0000-0002-3909-8389
Jordan, Michael I. http://orcid.org/0000-0001-8935-817X
Regier, Jeffrey http://orcid.org/0000-0002-1472-5235
Yosef, Nir http://orcid.org/0000-0001-9004-1225
Article History
First Online: 7 February 2022
Competing interests
: V.S. is a full-time employee of Serqet Therapeutics and has ownership interest in Serqet Therapeutics. F.J.T. reports consulting fees from Roche Diagnostics GmbH and Cellarity Inc., and ownership interest in Cellarity, Inc. N.Y. is an advisor to and/or has equity in Cellarity, Celsius Therapeutics and Rheos Medicines. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.